Literature DB >> 28921086

Hemodynamic effects of oral clonidine premedication in lumbar epidural anesthesia.

Toshiaki Nishikawa1, Keiichi Tajima1, Tetsu Kimura1, Tsuyoshi Satsumae1.   

Abstract

Clonidine, an α2-adrenergic agonist, has a potent sympatholytic effect and augments the pressor effect of ephedrine during general anesthesia. We evaluated whether oral clonidine premedication would alter the hemodynamic changes and enhance the pressor response to intravenous ephedrine during epidural anesthesia in 35 adult patients. They were randomly administered either premedication with clonidine approximately 5 μg·kg-1 po (n=17) or no clonidine medication (n=18). After establishment of epidural anesthesia, the hemodynamic response to ephedrine iv was measured in the awake state at 1-min intervals for 10 min. Then, the same hemodynamic measurement was repeated in the asleep state induced with midazolam iv. There were no differences in blood pressure (BP) and heart rate values between groups during the onset of epidural anesthesia, except that BP before epidural anesthesia was lower in the clonidine group than the control group (P<0.05). The magnitude and duration of pressor responses to ephedrine were comparable between groups in awake and asleep states. In conclusion oral clonidine premedication 5 μg·kg-1 alters neither the hemodynamic changes nor the pressor response to intravenous ephedrine during epidural anesthesia.

Entities:  

Keywords:  Alpha-2 adrenergic agonists; Clonidine; Epidural anesthesia

Year:  1996        PMID: 28921086     DOI: 10.1007/BF02483390

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  11 in total

1.  Oral clonidine preanesthetic medication augments the pressor responses to intravenous ephedrine in awake or anesthetized patients.

Authors:  T Nishikawa; T Kimura; N Taguchi; S Dohi
Journal:  Anesthesiology       Date:  1991-04       Impact factor: 7.892

Review 2.  Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia.

Authors:  M Maze; W Tranquilli
Journal:  Anesthesiology       Date:  1991-03       Impact factor: 7.892

3.  Clinical evaluation of clonidine added to lidocaine solution for epidural anesthesia.

Authors:  T Nishikawa; S Dohi
Journal:  Anesthesiology       Date:  1990-11       Impact factor: 7.892

4.  Lidocaine constricts or dilates rat arterioles in a dose-dependent manner.

Authors:  R A Johns; C A DiFazio; D E Longnecker
Journal:  Anesthesiology       Date:  1985-02       Impact factor: 7.892

5.  Postoperative analgesia by intravenous clonidine.

Authors:  J M Bernard; J L Hommeril; N Passuti; M Pinaud
Journal:  Anesthesiology       Date:  1991-10       Impact factor: 7.892

6.  Intravenous or epidural clonidine for intra- and postoperative analgesia.

Authors:  M De Kock; B Crochet; C Morimont; J L Scholtes
Journal:  Anesthesiology       Date:  1993-09       Impact factor: 7.892

7.  Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation.

Authors:  M Ghignone; L Quintin; P C Duke; C H Kehler; O Calvillo
Journal:  Anesthesiology       Date:  1986-01       Impact factor: 7.892

8.  Anesthesia for ophthalmic surgery in the elderly: the effects of clonidine on intraocular pressure, perioperative hemodynamics, and anesthetic requirement.

Authors:  M Ghignone; C Noe; O Calvillo; L Quintin
Journal:  Anesthesiology       Date:  1988-05       Impact factor: 7.892

9.  Enhancement of pressor response to intravenous phenylephrine following oral clonidine medication in awake and anaesthetized patients.

Authors:  S Inomata; T Nishikawa; S Kihara; Y Akiyoshi
Journal:  Can J Anaesth       Date:  1995-02       Impact factor: 5.063

10.  Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery.

Authors:  J W Flacke; B C Bloor; W E Flacke; D Wong; S Dazza; S W Stead; H Laks
Journal:  Anesthesiology       Date:  1987-07       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.